Company Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE
Equities
IL0010951403
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- ILa | - |
|
07-08 | SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio | MT |
06-03 | SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| - | - | 3 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +113.73% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 708,438 | 708,267 ( 99.98 %) | 0 | 99.98 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CLEARMIND MEDICINE INC. 0.24% | 7,692 | 0.24% | 12,923 $ |
Company contact information
![address Therapix Biosciences Ltd](https://cdn.zonebourse.com/static/address/10619695.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+26.44% | 45.54B | |
+34.49% | 24.51B | |
+26.79% | 16.48B | |
+21.96% | 14.66B | |
+73.31% | 14.3B | |
-0.05% | 6.79B | |
-11.51% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- SPRC Stock
- Stock
- Company Therapix Biosciences Ltd